Drug Trial Radar · NCT07796178
Evaluation of Lacrifill
Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Sep 2, 2026
Primary completion
Dec 31, 2026
Study completion Feb 15, 2027
Sponsor
- Lead sponsor
- Eye Research Associates, LLCAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 1, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Dry Eye Disease is defined as "a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. It is accompanied by increased osmolarity of the tear film and inflammation of the ocular surface.' 'By the The Tear Film and Ocular Surface Society. Despite there being a number of factors that impact DED however one factor that has been considered likely is that of a complication from ocular surgery itself. Which can cause both corneal nerve, and ocular surface damage. Therefore this study aims to determine how Lacrfill performs in preventing post-operative dry eye symptoms in those who have recently had unilateral cataract surgery.
Conditions
- Dry Eye
- Ocular Surface Disease
- Cataract Surgery
- Eyes Dry Feeling of
Interventions
LacrifillDrug
Participants will receive Lacrifill achemically crosslinked, particulate hyaluronic acid (HA) hydrogel intracanalicular occlusion device that is intended to occlude tear drainage
SalineDrug
Participants will be provided with a saline eye drop which is standard of care for those recovering from cataract surgery, and other complications that could cause symptoms related to Dry Eye Disease.
Primary outcomes
What the sponsor says the trial is designed to measure.
- OSDI Scores at the 1-month post-operative visit compared to pre-treatment (0-100 scale)Time frame: 1-month post operative compared to pre-treatment
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Kannarr Eye Care
Pittsburg, Kansas · Recruiting
Insight Eyecare Specialties Inc
Kansas City, Missouri · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.